U.S. market Closed. Opens in 17 hours 11 minutes

YI | 111, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.5600 - 0.6590
52 Week Range 0.5600 - 2.6800
Beta 0.35
Implied Volatility 598.82%
IV Rank 56.49%
Day's Volume 422,710
Average Volume 102,258
Shares Outstanding 85,664,320
Market Cap 47,972,019
Sector Healthcare
Industry Medical - Pharmaceuticals
IPO Date 2018-09-12
Valuation
Profitability
Growth
Health
P/E Ratio -1.24
Forward P/E Ratio N/A
EPS -0.45
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 1,520
Country China
Website YI
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
YI's peers: CJJD, PETS, WBA, BIMI, LFLY, FFLWF, GABLF, RAD, HITI, MEDS, MDVL
*Chart delayed
Analyzing fundamentals for YI we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see YI Fundamentals page.

Watching at YI technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on YI Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙